Cytokine-induced macrophage differentiation: A tale of 2 genes

Clinical and Investigative Medicine

Volumn 22, Issue 6, 1999, Pages 236-255

  Winston, Brent W ^a,b   Krein, Peter M ^b   Mowat, Connie ^b   Huang, Yong ^b  

^a Departments of Critical Care Medicine   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; NITRIC OXIDE SYNTHASE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; ENZYME INDUCTION; GENE; GENE CONTROL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERFERON TYPE II; MACROPHAGES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033489855     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. 1. Morrissette N, Gold E, Aderem A. The macrophage - a cell for all seasons. Trends Cell Biol 1999;9:199-201.
2. 2. Henson P, Riches D. Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation. In: M. Chignard et al, editors. Cells and cytokines in lung inflammation. New York: New York Academy of Sciences; 1994. p. 298-308.
3. 3. Riches DWH, Underwood GA. Expression of interferon-β during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state. J Biol Chem 1991;266(36):24785-92.
4. 4. Lake FR, Noble PW, Henson PM, Riches DW. Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha. J Clin Invest 1994;93(4):1661-9.
5. 5. Riches DWH, Chan ED, Zahradka EA, Winston BW, Remigio LK, Lake FR. Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide synthase by mouse macrophages. J Biol Chem 1998;273(35): 22800-6.
6. 6. Hevel JM, White KA, Marletta MA. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J Biol Chem 1991; 266(34):22789-91.
7. 7. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992;89:6711-5.
8. 8. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256(5054):225-8.
9. 9. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
10. 10. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997;94(10):5243-8.
11. 11. Liew FY, Li Y, Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990;145(12):4306-10.
12. 12. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in Cell 1995 Jun 30;81(7):following 1170]. Cell 1995;81(4):641-50.
13. 13. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998;187(6):917-28.
14. 14. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998;19(1):55-79.
15. 15. Le Roith D. Insulin-like growth factors. N Engl J Med 1997;336(9):633-9.
16. 16. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-53.
17. 17. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC, Crystal RG. Alveolar macrophages release an insulin-like growth factor 1-type molecule. J Clin Invest 1988;82:1685-93.
18. 18. Vanhee D, Gosset P, Wallaert B, Voisin C, Tonnel AB. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am J Respir Crit Care Med 1994;150:1049-55.
19. 19. Chen F, Deng HY, Ding GF, Houng DW, Deng YL, Long ZZ. Excessive production of insulin-like growth factor-I by silicotic rat alveolar macrophages. APMIS 1994;102:581-8.
20. 20. McAnulty RJ, Guerreiro D, Cambrey AD, Laurent GJ. Growth factor activity in the lung during compensatory growth after pneumonectomy: evidence of a role for IGF-I. Eur Respir J 1992;5:739-47.
21. 21. Melloni B, Lesur O, Bouhadiba T, Cantin A, Gegin R. Partial characterization of the proliferative activity for fetal lung epithelial cells produced by silica-exposed alveolar macrophages. J Leukoc Biol 1994;55:574-80.
22. 2-exposed rat lung. Am J Physiol 1996;271(1 Pt I)L:139-49.
23. 23. Maeda A, Kiyama K, Yamakido H, Ishioka S, Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 1996; 109(3):780-6.
24. 24. Veness-Meehan KA, Moats-Staats BM, Price WA, Stiles AD. Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury. Am J Respir Cell Mol Biol 1997;16(5):538-48.
25. 25. Goldstein RH, Poliks CF, Pilch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989;124:964-70.
26. 26. Uh S, Inoue Y, King TE Jr, Chan ED, Newman LS, Riches DWH. Morphometric analysis of insulin-like growth factor-I in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1626-35.
27. 27. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 1999;289(1):535-42.
28. 28. Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: effects on signal transduction pathways. Hepatology 1999;29(6):1743-51.
29. 29. Noble PW, Lake FR, Henson PM, Riches DW. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 1993;91(6):2368-77.
30. 30. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A 1993;90(20):9730-4.
31. 31. Underwood GA, Riches DWH. Transmembrane-mediated changes in (Ca2+) are involved in the signaling pathway leading to macrophage cytocidal differentiation: implications of localized changes in intracellular (Ca2+) and of interferon priming on Ca2+ utilization. Mol Biol Cell 1992;3:335-47.
32. 32. Lee JC, Laydon JT, Mcdonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372(22/29):739-46.
33. 33. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-3.
34. 34. Winston B, Riches D. Activation of p42mapk/erk2 following engagement of tumor necrosis factor receptor CD120a (p55) in mouse macrophages. J Immunol 1995;155(3):1525-33.
35. 35. Beutler B, Huffel V. Unraveling function in the TNF ligand and receptor families. Science 1994;264(29): 667-8.
36. 36. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Ann Rev Immunol 1999;17:331-67.
37. 37. Darnay B, Aggarwal B. Early events in TNF signaling: a story of associations and dissociations. J Leukoc Biol 1997;61(5):559-66.
38. 38. Tartaglia LA, Ayres MT, Wong GHW, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993;74:845-53.
39. 39. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81(4):505-12.
40. 40. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81(4):495-504.
41. 41. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995;81(4):513-23.
42. 42. Schievella A, Chen J, Graham J, Lin L. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 1997;272(18): 12069-75.
43. 43. Duan H, Dixit VM. RAIDD is a new 'death' adapter molecule. Nature 1997;385:86-9.
44. 44. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994;78:681-92.
45. 45. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996;86:937-47.
46. 46. Boldin MP, Mett IL, Wallach D. A protein related to a proteasomal subunit binds to the p55 TNF receptor upstream of its 'death domain'. FEBS Lett 1995;367: 39-44.
47. 47. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. Identification of a protein with homology to HSP 90 that binds the type I tumor necrosis factor receptor. J Biol Chem 1995;270:3574-81.
48. 48. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84(2):299-308.
49. 49. Takeuchi M, Rothe M, Goeddel DV. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J Biol Chem 1996;271(33):19935-42.
50. 50. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995;83(7):1243-52.
51. 51. Malinin NL, Boldin MP, Kovalenko AV, Wallack D. MAP3K-related kinase involved NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997;385(6616):540-4.
52. 52. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. IkappaB kinase-beta: NF-kappa B activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278(5339):866-9.
53. 53. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell 1997;90(2):373-83.
54. 54. May MJ, Ghosh S. IkappaB kinases: kinsmen with different crafts. Science 1999;284(5412):271-3.
55. 55. Fanger G, Gerwins P, Widmann C, Jarpe M, Johnson G. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 1997;7(1):67-74.
56. 56. Winston BW, Lange-Carter CA, Gardner AM, Johnson GL, Riches DWH. Tumor necrosis factor a rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc Natl Acad Sci U S A 1995;92:1-5.
57. 57. Chan E, Winston B, Jarpe M, Wynes M, Riches D. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc Natl Acad Sci U S A 1997;94(24):13169-74.
58. 58. Winston B, Chan E, Johnson G, Riches D. Activation of P38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages. J Immunol 1997;159(9):4491-7.
59. 59. Roebuck KA, Carpenter LR, Lakshminarayanan V, page SM, Moy JN, Thomas LL. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol 1999;65(3):291-8.
60. 60. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-64.
61. 61. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997;15:563-91.
62. 62. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994:264(5164):1415-21.
63. 63. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994;77(3):391-400.
64. 64. Kim SH, Cohen B, Novick D, Rubinstein M. Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2. Gene 1997;196(1-2):279-86.
65. 65. Cohen B, Novick D, Barak S, Rubinstein M. Ligand-induced association of the type I interferon receptor components. Mol Cell Biol 1995;15(8):4208-14.
66. 66. Li X, Leung S, Qureshi S, Darnell JE Jr, Stark GR. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-I gene transcription by interferon-alpha. J Biol Chem 1996;271(10):5790-4.
67. 67. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 1994;13(20):4798-806.
68. 68. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180(3):977-84.
69. 69. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (TRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 1994;14(2):1500-9.
70. 70. Pine R. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res 1997;25(21): 4346-54.
71. 71. Kajimoto Y, Rotwein P. Structure of the chicken insulin-like growth factor I gene reveals conserved promoter elements. J Biol Chem 1991;266:9724-31.
72. 72. Umayahara Y, Kawamori R, Wattada H, Imano E, Iwama N, Morishima T, et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 1994; 269:16433-42.
73. 73. Kajimoto Y, Umayahara Y. AP-1-like motif as a key to understanding the insulin-like growth factor-I (IGF-I) gene regulation. Endocrinol J 1998;45(1):1-12.
74. 74. Kim Y-M, Lee B-S, Yi K-Y, Paik S-G. Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Com 1997; 236:655-60.
75. 75. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269(7):4705-8.
76. 76. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994;263(5153):1612-5.
77. 77. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84(3):431-42.
78. 78. Salkowski CA, Barber SA, Detore GR, Vogel SN. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J Immunol 1996;156(9):3107-10.
79. 79. Spink J, Evans T. Binding of the transcription facotr interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J Biol Chem 1997;272(39):24417-25.
80. 80. Marks-Konczalik J, Chu SC, Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 1998;273(35):22201-8.
81. 81. Chan ED, Winston BW, Uh S-T, Wynes M, Rose DM, Riches DW. Evaluation of the role of mitogen-activated protein kinases in the expression of iNOS by IFNγ and TNFα in mouse macrophages. J Immunol 1999;162:415-22.
82. 82. Guo D, Dunbar JD, Yang CH, Pfeffer LM, Donner DB. Induction of Jak/STAT signaling by activation of the type I TNF receptor. J Immunol 1998;160:2742-50.
83. 83. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 1999; 289(3):459-71.
84. 84. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997;88(2):213-22.
85. 85. Riches D, Chan E, Winston B. TNF-alpha-induced regulation and signalling in macrophages. Immunobiology 1996;195(4-5):477-90.